In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells

Akira Shiose, Tohru Takaseya, Hyun Il Kim, Mariko Kobayashi, Tetsuya Horai, Santosh Rao, Yoko Arakawa, Masako Fujiki, Mark A. McCarthy, Yubiao Liu, Jan J. Lewandowski, Amy Davis, Kiyotaka Fukamachi

研究成果: ジャーナルへの寄稿記事

4 引用 (Scopus)

抄録

The purpose of this study was to demonstrate that a proprietary surfactant polymer (SP) coating does not adversely affect the hemodynamic performance of cardiopulmonary bypass (CPB) or gas exchange in oxygenators. The new coating was applied to a CPB circuit including cannulae, reservoir, oxygenator, and blood pump implanted into 12 pigs, divided into groups with either coated or noncoated pumps. CPB flow was maintained at a fixed level of approximately 2.4 L/min for 6 hours with full heparinization. Hemodynamic data and pump performance were recorded every hour, and blood samples were taken every 2 hours. After sacrifice, the CPB circuit and major organs were macroscopically examined. There was no significant difference in the oxygen transfer rate between the two groups. The coating did not adversely affect oxygenator inlet or outlet pressures. There was no significant difference between the two groups in microthrombi seen in the oxygenators. No thromboemboli were noted in the major organs on gross or histologic examination. In conclusion, this new SP coating did not decrease gas exchange performance, and its biocompatibility evaluations revealed no differences between coated and noncoated groups under aggressive heparin use.

元の言語英語
ページ(範囲)395-398
ページ数4
ジャーナルASAIO Journal
57
発行部数5
DOI
出版物ステータス出版済み - 9 1 2011

Fingerprint

Oxygenators
Glycocalyx
Endothelial cells
Cardiopulmonary Bypass
Surface-Active Agents
Polymers
Surface active agents
Endothelial Cells
Coatings
Hemodynamics
Pumps
Blood
Gases
Networks (circuits)
Biocompatibility
Heparin
Swine
Oxygen
Pressure

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

これを引用

In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells. / Shiose, Akira; Takaseya, Tohru; Kim, Hyun Il; Kobayashi, Mariko; Horai, Tetsuya; Rao, Santosh; Arakawa, Yoko; Fujiki, Masako; McCarthy, Mark A.; Liu, Yubiao; Lewandowski, Jan J.; Davis, Amy; Fukamachi, Kiyotaka.

:: ASAIO Journal, 巻 57, 番号 5, 01.09.2011, p. 395-398.

研究成果: ジャーナルへの寄稿記事

Shiose, A, Takaseya, T, Kim, HI, Kobayashi, M, Horai, T, Rao, S, Arakawa, Y, Fujiki, M, McCarthy, MA, Liu, Y, Lewandowski, JJ, Davis, A & Fukamachi, K 2011, 'In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells', ASAIO Journal, 巻. 57, 番号 5, pp. 395-398. https://doi.org/10.1097/MAT.0b013e318229ac9c
Shiose, Akira ; Takaseya, Tohru ; Kim, Hyun Il ; Kobayashi, Mariko ; Horai, Tetsuya ; Rao, Santosh ; Arakawa, Yoko ; Fujiki, Masako ; McCarthy, Mark A. ; Liu, Yubiao ; Lewandowski, Jan J. ; Davis, Amy ; Fukamachi, Kiyotaka. / In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells. :: ASAIO Journal. 2011 ; 巻 57, 番号 5. pp. 395-398.
@article{889a5a48292c43acaa6bba78e217d36c,
title = "In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells",
abstract = "The purpose of this study was to demonstrate that a proprietary surfactant polymer (SP) coating does not adversely affect the hemodynamic performance of cardiopulmonary bypass (CPB) or gas exchange in oxygenators. The new coating was applied to a CPB circuit including cannulae, reservoir, oxygenator, and blood pump implanted into 12 pigs, divided into groups with either coated or noncoated pumps. CPB flow was maintained at a fixed level of approximately 2.4 L/min for 6 hours with full heparinization. Hemodynamic data and pump performance were recorded every hour, and blood samples were taken every 2 hours. After sacrifice, the CPB circuit and major organs were macroscopically examined. There was no significant difference in the oxygen transfer rate between the two groups. The coating did not adversely affect oxygenator inlet or outlet pressures. There was no significant difference between the two groups in microthrombi seen in the oxygenators. No thromboemboli were noted in the major organs on gross or histologic examination. In conclusion, this new SP coating did not decrease gas exchange performance, and its biocompatibility evaluations revealed no differences between coated and noncoated groups under aggressive heparin use.",
author = "Akira Shiose and Tohru Takaseya and Kim, {Hyun Il} and Mariko Kobayashi and Tetsuya Horai and Santosh Rao and Yoko Arakawa and Masako Fujiki and McCarthy, {Mark A.} and Yubiao Liu and Lewandowski, {Jan J.} and Amy Davis and Kiyotaka Fukamachi",
year = "2011",
month = "9",
day = "1",
doi = "10.1097/MAT.0b013e318229ac9c",
language = "English",
volume = "57",
pages = "395--398",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - In vivo evaluation of a new surfactant polymer coating mimicking the glycocalyx of endothelial cells

AU - Shiose, Akira

AU - Takaseya, Tohru

AU - Kim, Hyun Il

AU - Kobayashi, Mariko

AU - Horai, Tetsuya

AU - Rao, Santosh

AU - Arakawa, Yoko

AU - Fujiki, Masako

AU - McCarthy, Mark A.

AU - Liu, Yubiao

AU - Lewandowski, Jan J.

AU - Davis, Amy

AU - Fukamachi, Kiyotaka

PY - 2011/9/1

Y1 - 2011/9/1

N2 - The purpose of this study was to demonstrate that a proprietary surfactant polymer (SP) coating does not adversely affect the hemodynamic performance of cardiopulmonary bypass (CPB) or gas exchange in oxygenators. The new coating was applied to a CPB circuit including cannulae, reservoir, oxygenator, and blood pump implanted into 12 pigs, divided into groups with either coated or noncoated pumps. CPB flow was maintained at a fixed level of approximately 2.4 L/min for 6 hours with full heparinization. Hemodynamic data and pump performance were recorded every hour, and blood samples were taken every 2 hours. After sacrifice, the CPB circuit and major organs were macroscopically examined. There was no significant difference in the oxygen transfer rate between the two groups. The coating did not adversely affect oxygenator inlet or outlet pressures. There was no significant difference between the two groups in microthrombi seen in the oxygenators. No thromboemboli were noted in the major organs on gross or histologic examination. In conclusion, this new SP coating did not decrease gas exchange performance, and its biocompatibility evaluations revealed no differences between coated and noncoated groups under aggressive heparin use.

AB - The purpose of this study was to demonstrate that a proprietary surfactant polymer (SP) coating does not adversely affect the hemodynamic performance of cardiopulmonary bypass (CPB) or gas exchange in oxygenators. The new coating was applied to a CPB circuit including cannulae, reservoir, oxygenator, and blood pump implanted into 12 pigs, divided into groups with either coated or noncoated pumps. CPB flow was maintained at a fixed level of approximately 2.4 L/min for 6 hours with full heparinization. Hemodynamic data and pump performance were recorded every hour, and blood samples were taken every 2 hours. After sacrifice, the CPB circuit and major organs were macroscopically examined. There was no significant difference in the oxygen transfer rate between the two groups. The coating did not adversely affect oxygenator inlet or outlet pressures. There was no significant difference between the two groups in microthrombi seen in the oxygenators. No thromboemboli were noted in the major organs on gross or histologic examination. In conclusion, this new SP coating did not decrease gas exchange performance, and its biocompatibility evaluations revealed no differences between coated and noncoated groups under aggressive heparin use.

UR - http://www.scopus.com/inward/record.url?scp=80052491722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052491722&partnerID=8YFLogxK

U2 - 10.1097/MAT.0b013e318229ac9c

DO - 10.1097/MAT.0b013e318229ac9c

M3 - Article

VL - 57

SP - 395

EP - 398

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 5

ER -